Press Releases

Pfizer, Moderna, BioNTech and AstraZeneca Lead Off in Mentor’s New Medical Investments Portfolio PLANO, Texas--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQB: MNTR) announced that it has added a business segment that focuses on the vaccine and associated medical companies involved in the fight against SARS-CoV-2. The initial public companies in the small internal portfolio are Pfizer,…

Trailing Annual Revenues Are Double Market Capitalization for Texas M&A Company PLANO, Texas--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQB: MNTR) announced that it had filed its quarterly 10-Q filing for the third quarter ended September 30, 2020, with the Securities and Exchange Commission. The Company reports that for the quarter ended September 30, 2020 Mentor had revenues of…

Annualized Current Revenues are 240% of Market Capitalization for M&A Company SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQB: MNTR) announced a 12.5% year-over-year revenue growth for the second three months of the year in its quarterly 10-Q filing for the second quarter ended June 30, 2020, filed with the Securities and Exchange Commission. The Company reports that for the…

Trailing Revenues Continue to Exceed Market Capitalization for M&A Company SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQB: MNTR) announced that it had filed its quarterly Form 10-Q filing for the first quarter ended March 31, 2020, with the Securities and Exchange Commission coincident with a move to the OTCQB. The Company reports that for the quarter ended March 31, 2020,…

Trailing Revenues Exceed Market Capitalization for M&A Company SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQX: MNTR) announced that it had filed its quarterly 10-Q filing for the third quarter ended September 30, 2019, with the Securities and Exchange Commission. The Company reports that for the quarter ended September 30, 2019 Mentor had revenues of $1,071,337 and gross…

Quarterly 10-Q Filing for Marijuana and Cannabis M&A Company SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQX: MNTR) announced that it had filed its quarterly 10-Q filing for the second quarter ended June 30, 2019 with the Securities and Exchange Commission. The Company reports that for the quarter ended June 30, 2019 Mentor had revenues of $1,029,749 and gross profit of…

SAN DIEGO, CA / ACCESSWIRE / May 16, 2019 / Mentor Capital, Inc. (OTCQX: MNTR) announced that it had filed its quarterly 10-Q filing for the first quarter ended March 31, 2019, with the Securities and Exchange Commission. The Company reports that for the quarter ended March 31, 2019, Mentor had revenues of $1,075,995 and gross profit of $370,374 with a resulting net loss attributable to Mentor…

Annual 10-K Filing for Marijuana and Cannabis M&A Company SAN DIEGO, CA / ACCESSWIRE / March 29, 2019 / Mentor Capital, Inc. (OTCQX: MNTR) announced that it had filed its annual 10-K filing for the year December 31, 2018, with the Securities and Exchange Commission. The Company reports that for the year ended December 31, 2018 Mentor had revenues of $5,281,533 and gross profit of $1,582,599…

Third Quarter 10-Q Filing for Marijuana and Cannabis M&A Company SAN DIEGO, CA / ACCESSWIRE / November 14, 2018 / Mentor Capital, Inc. (OTCQX: MNTR) announced that it had filed its quarterly 10-Q filing for the third quarter ended September 30, 2018, with the Securities and Exchange Commission. For the quarter ended September 30, 2018, Mentor had revenues of $1,031,622 and gross profit…

SAN DIEGO, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Mentor Capital, Inc. (OTCQX: MNTR) announced that it has been invited to present and answer investor questions at the OTCQX® Virtual Investor Conference on October 4, 2018, featuring US-based issuers traded on the OTCQX Best Market. Mentor’s CEO, Chet Billingsley, will be discussing the magnitude and potential of the American cannabis market,…